Application Information

Application Number : 2023/007846

Application Date : 13-02-2017

Application Type : EPC Fasikül

Grant Number : 2023-GE-423370

Grant Date : 05-07-2023

Registration Number : 2023 007846

Registration Date : 2023-07-21

Protection Type : Patent

European Patent Publication Number (B1) : EP3416684B1

European Patent Application Number : EP17706945.7

Applicants

Person No	Name	Address
7529111	REGENERON PHARMACEUTICALS INC.	777 OLD SAW MILL RIVER ROAD TARRYTOWN, NY 10591 A.B.D.

Inventors

Person No	Name	Address
7529108	Jesper GROMADA	C/O REGENERON PHARMACEUTICALS INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NEW YORK 10591 A.B.D.
7529110	Andrew J MURPHY	C/O REGENERON PHARMACEUTICALS INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NEW YORK 10591 A.B.D.
7529109	Viktoria GUSAROVA	C/O REGENERON PHARMACEUTICALS INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NEW YORK 10591 A.B.D.

Invention Information

Name Of Invention	BİR ANGPTL3 İNHİBİTÖRÜ UYGULAYARAK ATEROSKLEROZU TEDAVI ETMEK VEYA ÖNLEMEK İÇIN YÖNTEMLER
Summary Of Invention	Mevcut buluş, aterosklerozun ilerlemesini azaltmak için ANGPTL3 inhibitörlerinin kullanımı ile ilgilidir.

Attorney Information

Name	ZEHRA KÖLÜK DESTEK PATENT A.Ş.
Address	Maslak mah. Saat sk. Spıne tower no:5 Sarıyer/ İSTANBUL

Priority Information

Date of Priority	Priority Number	Country of Priority
17-02-2016	US 201662296110P	US

Classes of The Invention

Patent Application Procedures

Date	Date of Notification	Operation
27-01-2026		Yıllık Ücret Ödeme Talebi
28-01-2025		Yıllık Ücret Ödeme Talebi
		Vekil Atama Onaylandı.
10-06-2024		Vekil Atama Talebi
30-01-2024		Yıllık Ücret Ödeme Talebi
	06-07-2023	Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
05-07-2023		EPO'dan Gelen Patent Fasikül

Publications

Publication Date	Description
21-07-2023	Avrupa Patent Fasiküllerinin İlanı

Payment Dates

Row	Year	Payment Date	Amount Paid (₺)
8	2024	30-01-2024	3606.64
9	2025	28-01-2025	7470.0
10	2026	27-01-2026	10000.0